Human Antibody That Neutralizes Four Different Viruses and Has Potential to ... Science Daily (press release) RSV and MPV infections can be fatal in newborns and in immunosuppressed patients who have undergone stem cell or lung transplantation with a mortality up to 40%. A humanized antibody to RSV (Synagis) is currently used for prophylaxis in premature ... |
